Antineoplastic activity of novel N-1-sulfonypyrimidine derivatives

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1979-1986

  Glavas Obrovac, L ^a   Karner, I ^a   Zinic, B ^a   Pavelic, K ^a  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

Author keywords

Antitumor activity; Apoptosis; Human tumor cells; N 1 sulfonylpyrimidine derivatives

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSINE DERIVATIVE; DNA; DNA FRAGMENT; N1 SULFONYLPYRIMIDINE DERIVATIVE; ONCOPROTEIN; PHOSPHATIDYLSERINE; PROTEIN P53; PYRIMIDINE DERIVATIVE; RNA; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIPID BILAYER; LYMPH NODE METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; COLORING AGENTS; CYTOSINE; DNA; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICROSCOPY, FLUORESCENCE; PYRIMIDINES; RNA; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TUMOR CELLS, CULTURED; URACIL;

EID: 0034898514     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Atherosclerosis: Emerging pharmacological approaches
2. Antihyperglycaemic agents. Drug interaction of clinical importance
3. Oral antidiabetic drugs - An overview
4. Routine determination of sulfonylurea, imidazolinone, and sulphonamide herbicides at nanogram per litre concentrations by solid-phase extraction and liquid chromatography/mass spectrometry
5. Characterisation of intracellular distribution and activity in human adenocarcinoma cells of N-(-4-azidophenylsulfonyl)-N′-(4-chlorophenyl) urea (LY219703), a photoaffinity analogue of the tumor diarylsulfonylurea sulfenur
6. Evaluation of new anticancer agents against the MIAPaCa-2 and PANC-1 human pancreatic carcinoma xenografts
7. Sulfonylureas: A new class of cancer chemotherapeutic agents
8. Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenylurea) (LY181984) modulated by redox
9. Sulfonimidamide analogs of oncolytic sulfonylureas
10. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-β-D-ribopentofuranosyl)-cytosine, 1-(3-C-ethynyl-β-D-ribopenthofuranosyl) uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity
11. Metabolism and ribonucleotide reductase inhibition of (E)-2′-deoxy-2′-(fluoromethylene) cytidine, MDL 101, 731, in human cervical carcinoma HeLa S3 cells
12. The development of new chemotherapeutics agents
13. Impact of 9-(2-phosphonylmethoxiethyl) adenine on (deoxy)ribonucleotide metabolism and nucleic acid synthesis in tumor cells
14. Structure-activity relatioship of pyrimidine base analogs as ligands of orotate phosphoribosyltransferase
15. Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil
16. Studies on antitumor agents. V. Synthesis and antitumor activities of 5-fluorouracil derivatives
17. Elucidation of pathways of 5-fluorouracil metabolism in xenografts on human colorectal adenocarcinoma
18. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation
19. Synthesis of the sulfonylpyrimidine derivatives as a new type of sulfonyclcycloureas
20. In vitro antitumor activity of mitomycin C derivative (RM-49) and a new anticancer antibiotic (FK 973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay
21. Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis
22. Immunohistochemical detection of c-myc oncoprotein in parafin embedded tissues
23. Principles of Chemotherapy
24. Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells
25. Bcl-2 protein expression and long term survival in breast cancer
26. Histopathological evaluation of apoptosis in cancer
27. Early redistribution of plasma phosphatydilserine is a general feature of apoptosis regardless of initiating stimulus inhibition by overexpression of Bcl-2 and Abl
28. A matter of life and cell death
29. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
30. Apoptosis. Its significance in cancer and cancer therapy
31. Critical aspects in the analysis of apoptosis and necrosis
32. Apoptosis. The role of endonuclease
33. Angagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells
34. Ras signalling and apoptosis
35. The retinoblastoma protein: A master regulator of cell cycle, differentiation and cell apoptosis
36. p53, from inductive signal to cellular effect
37. The influence of the p53 gene on the in vitro chemosensitivity of colorectal cancer cells